Cailin Conner

DocwireNews

A recent retrospective, single-center study published in <a href="https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(23)00685-X/fulltext" target="_blank" rel="noopener">Diabetes Research and Clinical Practice</a> found a high incidence of skin reactions to adhesive devices used in the treatment of type 1 diabetes in children, specifically continuous subcutaneous insulin infusion (CSII) or continuous glucose monitoring (CGM).
The study, which included 198 children with type 1 diabetes, involved the completion of a standardized questionnaire during their ongoing care. This questionnaire aimed to evaluate the frequency and nature of skin reactions, their impact, and the treatments adopted. Furthermore, the study examined the demographic characteristics of children who experienced these skin reactions, employing both univariate and multivariate analyses.
The findings revealed that approximately 33.8% of the patients reported active skin reactions. Among this group, 30.4% of the skin reactions were associated with CSII and 23.5% with CGM. Interestingly, pediatric patients who experienced skin reactions were generally younger, with a mean age of 10.6 years compared with 12.34 years in the unaffected group. Additionally, these patients were diagnosed with diabetes at an earlier age, with an average age of 5.59 years compared with 7.08 years in those without skin reactions.
The study also assessed the impact of atopy, with 76.1% of the children with skin reactions having a history of atopic conditions compared with 54.1% in the group without reactions. A multivariate analysis highlighted the significant association between a personal history of atopy and skin reactions, with an odds ratio of 2.56.
This study underscores the notable incidence of skin reactions caused by adhesive devices used in the treatment of type 1 diabetes in children. The findings emphasize the importance of considering skin-related challenges when utilizing CSII and CGM technologies. It further highlights the relevance of assessing a child&#8217;s history of atopy as a predictive factor for skin reactions.

Andrew Moreno

IWG 2023, 2006 MDS Criteria Assessments of Ivosidenib for mIDH1 Disease Compared

ASH 2024

Venetoclax, Cladribine, Idarubicin, Cytarabine Regimen Evaluated in AML, High-Risk MDS

Omacetaxine Plus Azacitidine for Excess Blasts-MDS: Safety, Long-Term Outcomes Favorable

Latest News

Skin Reactions Secondary to CGM and Continuous Subcutaneous Insulin Infusion in Pediatric Patients With Diabetes

Diabetes

According to a of 198 children with type 1 diabetes, there was a significant incidence of skin reactions, particularly in those using CGM.

Skin Reactions Secondary to CGM and Continuous Subcutaneous Insulin Infusion in Pediatric Patients 

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe